50
Paediatric blood transfusion Dr. Chitra Rajeswari T Dr. Lokesh Kashyap www.anaesthesia.co.in [email protected]

Paediatric blood transfusion Dr. Chitra Rajeswari T Dr. Lokesh Kashyap [email protected]@gmail.com

Embed Size (px)

Citation preview

Paediatric blood transfusion

Dr. Chitra Rajeswari TDr. Lokesh Kashyap

www.anaesthesia.co.in [email protected]

Why to transfuse blood Basic physiological function is to ensure

adequate oxygenation of the tissues Physiology of oxygen transport

Hypoxic hypoxia Anaemic hypoxia

Histotoxic hypoxiaStagnant hypoxia

Anaemic hypoxia

Oxygen delivery DaO2

=Cardiac output X CaO2 [oxygen content]

Oxygen content[Hb saturation X 1.34 X Hb conc] + 0.003 X PO2Amount of oxygen carried by 100 ml of blood

Fetal hemoglobin

Cardiac reserve Increased metabolism

Fetal hemoglobin

HbF – 70-80% of full term and 97% of premature infants’ total hemoglobin at birth

Fetal hemoglobin

Shorter life span of 90 days (HbA- 120 days)

HbF interacts poorly with 2,3,DPG P50 with HbF is 19 mmHg P50 with HbA is 27 mmHg

Leftward shift of ODC

ODC

Hemoglobin for equivalent oxygen delivery

P 50 Hb

Adult 27 10

Infants [>3 month]

30 8.2

Infants [<3 month]

24 14.7

Motoyama et al. 1990

6 months- 6 years12

7-13 years 136 months- 6 years 127- 13 years 13

Preoperative hemoglobin At the time of nadir

Term infant with Hb < 9 g/dl Preterm infant <7 g/dl

Haemoglobin levels that are adequate for the older patients may be suboptimal in the younger infant

Fetal hemoglobin

Cardiac reserve Increased metabolism

Adult vs children - cardiac reserve

• Children have a higher cardiac output to blood volume ratio than adults

Estimated circulating blood volume

Age Blood volume (ml/kg)

Premature infant 90-100

Term infant – 3 months 80-90

Children older than 3 months 70

Very obese children 65

Sandra et al. Pediatric anesthesia 2005

• The neonatal myocardium operates at near maximum level of performance as a baseline

• The newborn’s heart may be unable to compensate for a decreased oxygen carrying capacity by increasing cardiac output

• The neonatal myocardium will also suffer a greater degree of decompensation when exposed to decreased oxygen delivery

Adult vs children - cardiac reserve

Metabolism Oxygen consumption

When to transfuse blood?

MABL MABL = Starting – Target hematocrit

Blood loss more than this target value then RBC cell transfusion should be initiated

65 ml of packed RBC [Hct 70%] = 150 ml of whole blood [Hct 30%]

0.5 ml of PRBC for each ml of blood loss beyond the MABL

1 ml/kg PRBC raises the hematocrit by 1.5%

Starting hematocritX EBV

May benefit from higher hematocrit Preterm and term infants Cyanotic congenital heart disease Large ventilation/ perfusion mismatch High metabolic demand Respiratory failure

Guidelines for perioperative management of anemia

Minimum acceptable hemoglobin

Infants > 3 months 8 g/dl

Infants < 2 months Ex-premie <52 weeks PCA

10g/dl

Infants in first week of lifeWeight < 1500 gWith cardiopulmonary disease

12g/dl

Guidelines contd… In an elective setting, anemia should be

evaluated and treated,surgery may be postponed for a month or longer

Cumulative record of blood loss should be kept for critically ill infants and loss replaced when it exceeds 10% of blood volume

In an emergency setting, anesthesia administered with extreme caution Maintain high PaO2 Adequate cardiac output Adequate intravascular volume Avoid factors increasing oxygen consumption Avoid leftward shift of ODC

Guidelines contd…

Oxygen extraction ratioas hematocrit drops to 15%, OER increases

from 38 to 60% Central venous Po2

- Decline of pVo2 is the most sensitive indicator of anemia

- Normal => 38 mm Hg

Holland et al. 1987

Guidelines contd…

Pediatric transfusions – guidelines

Platelet transfusions platelet count less than 50000 in acute bleeding Less than 1 lakh for intracranial and Subarachnoid or

extra corporeal circulation procedures 5 mL/kg - 10 mL/kg causes a rise of platelets of 50 to

100 * 109/L Fresh frozen plasma

aPTT or PT > 1.5 times normal 10-15 ml/kg

Cryoprecipitate Fibrinogen 100 mg/dl 1 unit /10 kg BW raises plasma fibrinogen by 50 mg/dl

Acute transfusion reactions ( < 24 hours) Febrile nonhemolytic reaction Urticarial/allergic reaction Acute hemolytic reaction Bacterial contamination and sepsis Fluid overload Anaphylaxis TRALI

Delayed transfusion reaction Infection Delayed hemolytic reaction Post transfusion purpura Graft Vs host disease Iron overload

Transfusion reactions

TRALI TRALI

Acute hypoxemia Non-cardiogenic pulmonary edema During or after transfusion

Leading cause of transfusion-related mortality in 2003 – FDA, TRALI conference

Underdiagnosis & underreporting

Incidence All plasma-containing blood & blood

components 1/5,000 blood & blood component 1/2,000 plasma-containing component 1/7,900 units of FFP 1/432 units of whole blood derived platelets

Pathophysiology

Leukocyte antibodies Biologically active substance

Lipids & cytokinesNeutrophil priming activity

Leukocyte Antibodies Neutrophil in pulmonary capillary → pulmonary damage

& capillary leak Antibody to donor leukocyte Ab to HLA I, II, granulocyte, monocyte, IgA

Management Supportive Stop transfusion if timely recognition Oxygen and ventilatory support as employed in

ARDS Avoid blood from multiparous female donors

Immunologic Transfusion related graft vs host disease Lymphocytes in transfused blood component proliferate

and cause host tissue destruction Immunocompromised patient Premature infants Children with cancer or severe systemic illness Acute blood loss Cardiopulmonary bypass

Prevented by irradiated blood

Pediatric transfusions - neonates Neonates have some specific

considerations with respect to anesthesia and blood products. Major hemolytic reaction (ABO)

occurs less frequently in neonates compared with older children and adults.

For the first 3–4 months of life, infants are unable to form alloantibodies to RBC antigens.

After 4 months of age, hemolytic reactions become a potential factor

Massive blood transfusion

Definition Loss of one or more circulating blood volume in

24 hour 50% blood volume in 3 hours Loss occurring at the rate of 2-3 ml/kg/min

Problems of massive transfusion Hypocalcemia Hyperkalemia Hypomagnesemia Hypothermia Volume overload Dilutional coagulopathy Acid base changes Shift of ODC curve Microaggregate delivery TRALI

Hypocalcemia Degree of ionized hypocalcemia depends upon

Blood product transfused Rate Hepatic blood flow Hepatic function

Hypocalcemia

Degree of ionized hypocalcemia depends upon Blood product transfused Rate Hepatic blood flow Hepatic function

FFP

Decreased ability to metabolise by neonate

> 1 ml / kg / min

Myocardial depression

Hypocalcemia

Decreased ability to metabolise by neonate

Inhalational agents

Prevention of hypocalcemia Rate should be < 1 ml / kg / min If more than > 1 ml / kg / min calcium should

also be transfused Calcium infusion

Calcium chloride 5-10 mg/kg Calcium gluconate 15-30 mg/kg

Frequent measurement of ionised calcium

Hyperkalemia Blood components with high potassium

Whole blood Irradiated blood Near the expiry date

Prevention of hyperkalemia Washing of erythrocytes Newer blood (< 7 days) Avoiding whole blood and prefer packed RBC

Treatment CaCl2 15-20 mg/kg Calcium gluconate 45-60 mg/kg 1-2 min intervals until the arrhythmia is resolved Glucose and insulin Hyperventilation Albuterol kayexalate

Hypomagnesemia Result of citrate toxicity Stabilizes the resting membrane potential Life threatening arrhythmia that dose not

respond to exogenous calcium therapy needs magnesium sulphate

25-50 mg/kg followed by 30-60 mg/kg/24 hours

Acid-base changes RBC metabloism can elevate the dissolved CO2

to 180-210 mmHg Anaerobic metabolism increases the lactic acid

content Initial transient combined respiratory and

metabolic acidosis Citrate metabolism leads to metabolic alkalosis

Hypothermia Shift to left of ODC curve – decreased oxygen

delivery Apnea Hypoglycemia Decreased drug metabolism Increased oxygen consumption Coagulopathy

Coagulopathy Massive blood transfusion leads to

thrombocytopenia 40%, 20% and 10% of starting platelet count is

seen after 1st, 2nd and 3rd blood volume loss Dilution and loss of clotting factors Clotting factor deficiency should be anticipated

after one blood volume loss

Recombinant factor VIIa Retrospective review of use of factor 7a in

children undergoing major neurosurgical procedures experiencing massive uncontrollable hemorrhage

Useful adjunct to control life threatening bleeding,but more extensive research is needed

Uhring et al Ped crit care med, 2007

Mechanism of action

Blood Conservation Preoperative Autologous Donation Acute Normovolemic Hemodilution Intraoperative Blood Salvage Preoperative Erythropoietin Positioning Hypotensive anaesthesia Pharmacological enhancement of hemostasis Artificial blood

www.anaesthesia.co.in [email protected]